\n<\/p>\n
Mordor Intelligence has published a new report on the infectious disease diagnostics\u00a0market, offering a comprehensive analysis of trends, growth drivers, and future projections.<\/span>\u00a0<\/span><\/p>\n Introduction<\/span><\/b>\u00a0<\/span><\/p>\n According to Mordor Intelligence, the\u00a0<\/span>infectious disease diagnostics market size<\/span><\/a>\u00a0was valued at USD 46.81 billion in 2025 and is expected to grow from USD 48.38 billion in 2026 to reach USD 57.05 billion by 2031, registering a CAGR of 3.35% during the infectious disease diagnostics market forecast period.<\/span>\u00a0<\/span><\/p>\n This consistent infectious disease diagnostics market growth reflects a shift from pandemic-driven demand toward routine and long-term disease monitoring. The infectious disease diagnostics industry is now focusing on a broader set of conditions, including endemic infections, antimicrobial resistance, and emerging pathogens. Laboratories are also adjusting their operations to manage changing testing volumes while\u00a0maintaining\u00a0efficiency and accuracy.<\/span>\u00a0<\/span><\/p>\n Key Trends in the Infectious Disease Diagnostics Market<\/span><\/b>\u00a0<\/span><\/p>\n Shift Toward Endemic and Emerging Disease Testing<\/span><\/b>\u00a0<\/span><\/p>\n A major trend shaping the infectious disease diagnostics market trends is the transition from pandemic-focused testing to a broader disease portfolio. Laboratories are increasingly prioritizing testing for vector-borne diseases, antimicrobial-resistant infections, and newly emerging pathogens. This shift supports sustained infectious disease diagnostics market growth by reducing reliance on a single disease category.<\/span>\u00a0<\/span><\/p>\n Expansion of Software and Workflow Solutions<\/span><\/b>\u00a0<\/span><\/p>\n Software and informatics tools are becoming an integral part of the infectious disease diagnostics industry. Laboratories are adopting digital platforms to manage large volumes of data, improve reporting accuracy, and\u00a0optimize\u00a0workflow efficiency. These tools are contributing to improved operational performance and are gradually influencing the infectious disease diagnostics market share.<\/span>\u00a0<\/span><\/p>\n Increasing Competition from New Technologies<\/span><\/b>\u00a0<\/span><\/p>\n The entry of new diagnostic methods such as CRISPR-based testing, isothermal amplification, and AI-supported analysis is influencing infectious disease diagnostics market trends. These approaches are offering faster and more flexible testing solutions, encouraging both established companies and new entrants to compete for a stronger position in the infectious disease diagnostics market.<\/span>\u00a0<\/span><\/p>\n Continued Importance of Reagents and Consumables<\/span><\/b>\u00a0<\/span><\/p>\n Reagents continue to form the backbone of revenue in the infectious disease diagnostics industry. Despite the introduction of advanced tools and platforms, the consistent demand for assays, kits, and consumables ensures steady infectious disease diagnostics market growth. Laboratories rely heavily on these products for routine testing across multiple disease categories.<\/span>\u00a0<\/span><\/p>\n